Conversely, no correlations were found between the rTMS outcome and polymorphisms in either DRD2 or COMT Val/Met genotypes, in patients with orofacial or central post-stroke pain stimulated over M1 or S2 (Lindholm et al., 2015; Ojala et al., 2022). This evidence concerns the gene DRD2 and Stroke.